Seborrheic dermatitis can be a frustrating and persistent skin condition. Whether it's the red, flaky patches on your scalp ...

Roflumilast cream 0.15% is efficacious and safe for the treatment of atopic dermatitis (AD) among children and adults, according to study findings published in JAMA Dermatology. Researchers assessed ...

It is not common in children but appears in puberty and has a peak incidence in adults ... with seborrheic dermatitis. It also seems increased in patients with neurological diseases such as ...

or seborrheic dermatitis–like morphology) and can occur with normal levels of total and allergen-specific serum immunoglobulin E in about a third of cases. Adult AD is mainly mild to moderate ...

The point prevalence of atopic dermatitis was highest in those aged 0 to 5 years among children and adolescents and in those aged 18 to 59 years among adults. The estimated global point prevalence ...

EBGLYSS is approved for use in adults and children aged 12 years and older, providing a new option for controlling this chronic and debilitating skin condition. Atopic dermatitis is characterized ...

This is especially important in cases where the cause of the rash is in question. Diagnostic testing is needed more often for adults than young children because eczema is common in kids and usually ...

The HORIZON study is the first of eight phase 3 trials in the ROCKET clinical trial program assessing rocatinlimab in adults and adolescents with atopic dermatitis.

The point prevalence of atopic dermatitis was highest in those aged 0 to 5 years among children and adolescents and in those aged 18 to 59 years among adults. The estimated global point prevalence of ...

Topline results were announced from a phase 3 trial evaluating rocatinlimab for the treatment of moderate to severe atopic dermatitis. The randomized, double-blind, placebo-controlled ROCKET HORIZON ...